Profile Solutions Stock Forecast for 2023 - 2025 - 2030
Updated on 05/17/2024
Stock Rating
0
Price Target
$0.00
Consensus
-
Upside
0.00%
Analysts
0
Stock Rating
0
Upside
0.00%
Analysts
0
Price Target
$0.00
Profile Solutions Stock Forecast and Price Target
In recent months, notable analysts have provided yearlong price targets for Profile Solutions, with the average target coming in at $0.00. If it were to be achieved, this would result in a potential upside of approximately 100 percent from the most recent closing price in August, 2023. The high end is $0.00, and the low is $0.00. If you are interested in PSIQ stock, it is important to also consider its competitors.
$0.00
0.00% Upside
-
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| LLY Stock Forecast | Eli Lilly and | Outperform |
16
|
$771.12 | Buy/Sell | $636.99 | 13.80% |
| JNJ Stock Forecast | Johnson & Johnson | Outperform |
9
|
$154.28 | Buy/Sell | $174.55 | 10.19% |
| MRK Stock Forecast | Merck | Outperform |
2
|
$130.88 | Buy/Sell | $130.51 | 9.26% |
| PFE Stock Forecast | Pfizer | Outperform |
2
|
$28.92 | Buy/Sell | $32.87 | 5.46% |
| VRTX Stock Forecast | Vertex Pharmaceuticals Inc | Outperform |
12
|
$440.64 | Buy/Sell | $457.59 | 3.76% |
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| REGN Stock Forecast | Regeneron Pharmaceuticals | Outperform |
2
|
$967.98 | Buy/Sell | $961.26 | 8.47% |
| BMY Stock Forecast | Bristol-Myers Squibb | Hold |
2
|
$44.11 | Buy/Sell | $58.15 | 22.42% |
| ZTS Stock Forecast | Zoetis | Outperform |
18
|
$173.71 | Buy/Sell | $220.47 | 26.65% |
.jpg)
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| ALNY Stock Forecast | Alnylam Pharmaceuticals Inc | Outperform |
7
|
$151.22 | Buy/Sell | $245.24 | 43.83% |
| BAX Stock Forecast | Baxter International Inc | Hold |
17
|
$35.17 | Buy/Sell | $44.86 | 25.11% |
| VTRS Stock Forecast | Viatris Inc | Hold |
8
|
$11.02 | Buy/Sell | $11.73 | 8.89% |
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| UTHR Stock Forecast | United Therapeutics | Outperform |
12
|
$272.22 | Buy/Sell | $284.08 | 10.20% |
| CTLT Stock Forecast | Catalent | Hold |
15
|
$55.25 | Buy/Sell | $49.29 | 14.93% |
| CYTK Stock Forecast | Cytokinetics | Outperform |
10
|
$59.92 | Buy/Sell | $87.92 | 56.88% |
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| IONS Stock Forecast | Ionis Pharmaceuticals | Outperform |
9
|
$37.62 | Buy/Sell | $55.60 | 59.49% |
| BCPC Stock Forecast | Balchem | Outperform |
18
|
$156.63 | Buy/Sell | $145.00 | 5.34% |
| MDGL Stock Forecast | Madrigal Pharmaceuticals | Outperform |
4
|
$217.17 | Buy/Sell | $315.92 | 77.74% |
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| PRGO Stock Forecast | Perrigo Co PLC | Outperform |
16
|
$30.10 | Buy/Sell | $44.75 | 32.89% |
| NEOG Stock Forecast | Neogen | Outperform |
16
|
$13.41 | Buy/Sell | $37.00 | 26.77% |
| CORT Stock Forecast | Corcept Therapeutics | Buy |
16
|
$27.54 | Buy/Sell | $35.67 | 45.24% |
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| INDV Stock Forecast | Indivior PLC | Buy |
14
|
£13.52 | Buy/Sell | £28.89 | 128.77% |
| TGTX Stock Forecast | TG Therapeutics | Outperform |
9
|
$17.42 | Buy/Sell | $29.44 | 98.05% |
| AMPH Stock Forecast | Amphastar Pharmaceuticals | Outperform |
14
|
$42.74 | Buy/Sell | $69.00 | 45.06% |
.jpg)